Cargando…

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

BACKGROUND: Sarcoidosis is a granulomatous disorder of unknown etiology. The term of immunoangiostasis has been addressed by various studies as potentially involved in the disease pathogenesis. The aim of the study was to investigate the expression of the master regulator of angiogenesis hypoxia ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzouvelekis, Argyris, Ntolios, Paschalis, Karameris, Andreas, Koutsopoulos, Anastasios, Boglou, Panagiotis, Koulelidis, Andreas, Archontogeorgis, Kostas, Zacharis, George, Drakopanagiotakis, Fotis, Steiropoulos, Paschalis, Anevlavis, Stavros, Polychronopoulos, Vlassis, Mikroulis, Dimitrios, Bouros, Demosthenes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536569/ https://www.ncbi.nlm.nih.gov/pubmed/23181555 http://dx.doi.org/10.1186/1756-0500-5-654

Ejemplares similares

Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Idiopathic Pulmonary Hemosiderosis in Adults: A Case Report and Review of the Literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Acute fibrinous and organising pneumonia: a case report and review of the literature
por: Tzouvelekis, Argyris, et al.
Publicado: (2009)

Formoterol in the management of chronic obstructive pulmonary disease
por: Steiropoulos, Paschalis, et al.
Publicado: (2008)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Lung Nodules and Hypoxemia: Any Association?
por: Chadia, Konstantina, et al.
Publicado: (2021)

New developments in the management of COPD: clinical utility of indacaterol 75 μg
por: Steiropoulos, Paschalis, et al.
Publicado: (2013)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
por: Ntolios, Paschalis, et al.
Publicado: (2021)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006)

HbA(1c) is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
por: Papanas, Nikolaos, et al.
Publicado: (2009)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Serum biomarkers in interstitial lung diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

Chemotherapy-induced changes in bronchoalveolar lavage fluid CD4 + and CD8 + cells of the opposite lung to the cancer
por: Karpathiou, Georgia, et al.
Publicado: (2020)

Decreased Apoptotic Rate of Alveolar Macrophages of Patients with Idiopathic Pulmonary Fibrosis
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2012)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004)

Predictors of obstructive sleep apnea in males with metabolic syndrome
por: Papanas, Nikolaos, et al.
Publicado: (2010)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome
por: Voulgaris, Athanasios, et al.
Publicado: (2021)

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2013)

Is There Evidence of Early Vascular Disease in Patients with Obstructive Sleep Apnoea Without Known Comorbidities? Preliminary Findings
por: Steiropoulos, P, et al.
Publicado: (2013)

Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome)
por: Voulgaris, Athanasios, et al.
Publicado: (2023)

Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment
por: Archontogeorgis, Kostas, et al.
Publicado: (2015)

Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars
por: Tzouvelekis, Argyris, et al.
Publicado: (2019)

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2023)

Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?
por: Steiropoulos, Paschalis, et al.
Publicado: (2010)

Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?
por: Voulgaris, Athanasios, et al.
Publicado: (2023)

Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004)

Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy
por: Karpathiou, Georgia, et al.
Publicado: (2020)

DNA Methylation in Pediatric Obstructive Sleep Apnea: An Overview of Preliminary Findings
por: Perikleous, Evanthia, et al.
Publicado: (2018)

Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea
por: Michailidis, Vassileios, et al.
Publicado: (2011)

Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
por: Archontogeorgis, Konstantinos, et al.
Publicado: (2014)

The role of vitamin D in obstructive sleep apnoea syndrome
por: Archontogeorgis, Kostas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_817q5bpibhr5hji1b88m346d50